Detection of Fentanyl and Fentanyl Analogs

Area of Science:

• Forensic Toxicology
• Analytical Chemistry
• Pharmacology

Background:

• Illicitly manufactured fentanyl (IMF) and its analogs are driving a surge in opioid overdose fatalities.
• Accurate detection of fentanyl exposure is critical for public health and clinical management.
• Existing fentanyl testing methods often lack sensitivity for prevalent fentanyl analogs.

Purpose of the Study:

• To review current immunoassay and mass spectrometry techniques for detecting fentanyl and its analogs.
• To assess the sensitivity and specificity of various analytical methods.
• To highlight challenges and advancements in fentanyl detection methodologies.

Main Methods:

• Review of scientific literature on fentanyl and fentanyl analog detection assays.
• Analysis of immunoassay performance characteristics (sensitivity, cross-reactivity).
• Evaluation of mass spectrometry techniques (e.g., LC-MS/MS) for fentanyl and metabolite identification.

Main Results:

• Immunoassays show variable sensitivity to fentanyl and its analogs; many common analogs are missed.
• Mass spectrometry offers superior specificity and sensitivity for detecting fentanyl and its metabolites, including norfentanyl.
• Challenges remain in detecting novel fentanyl analogs and quantifying exposure levels accurately.

Conclusions:

• Sensitive and specific detection of fentanyl and its analogs is crucial for addressing the opioid crisis.
• Mass spectrometry-based methods are currently the gold standard for accurate fentanyl detection.
• Further development of broad-spectrum assays is needed to improve public health surveillance and clinical diagnostics.